- ATC Code
- Indications and NEMLC Recommendations 1
- Indications and NEMLC Recommendations 2
- Indications and NEMLC Recommendations 3
- Indications and NEMLC Recommendations 4
- Indications and NEMLC Recommendations 5
- Indications and NEMLC Recommendations 6
ATC CODE
- H01AC01
INDICATIONS AND NEMLC RECOMMENDATIONS
INDICATIONS AND NEMLC RECOMMENDATIONS 1
INDICATION
- Turner’s syndrome.
NEMLC RECOMMENDATION
- Not Approved
REVIEW INDICATORS
- Improved cost-effectiveness.
DATE RATIFIED
- 20 September 2007
INDICATIONS AND NEMLC RECOMMENDATIONS 2
INDICATION
- Prader Willi syndrome.
NEMLC RECOMMENDATION
- Not Approved
REVIEW INDICATORS
- Price.
DATE RATIFIED
- 20 September 2007
INDICATIONS AND NEMLC RECOMMENDATIONS 3
INDICATION
- Intrauterine growth failure.
NEMLC RECOMMENDATION
- Not Approved
REVIEW INDICATORS
- Price.
DATE RATIFIED
- 20 September 2007
INDICATIONS AND NEMLC RECOMMENDATIONS 4
INDICATION
- Idiopathic short stature.
NEMLC RECOMMENDATION
- Not Approved
REVIEW INDICATORS
- Improved cost-effectiveness.
DATE RATIFIED
- 20 September 2007
INDICATIONS AND NEMLC RECOMMENDATIONS 5
INDICATION
- Chronic renal insufficiency.
NEMLC RECOMMENDATION
- Not Approved
REVIEW INDICATORS
- Evidence of benefit.
DATE RATIFIED
- 20 September 2007
INDICATIONS AND NEMLC RECOMMENDATIONS 6
INDICATION
- Growth hormone deficiency.
NEMLC RECOMMENDATION
- Approved
Approved for confirmed growth hormone deficiency for use by endocrinologists only.
Rationale:- The condition is a well-defined deficiency state that can be managed and monitored.
- Number of patients requiring treatment is small.
REVIEW INDICATORS
- New evidence on quality of life assessment in local and specific populations.
DATE RATIFIED
- 24 July 2008